GnT-V-mediated aberrant N-glycosylation of TIMP-1 promotes diabetic retinopathy progression
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09388-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Xiaoting Xi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, The First Affiliated Hospital of Kunming Medical University, No. 295, Xichang Road, Kunming, 650032, Yunnan, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Retinopathy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Province Applied Basic Research (Kunming Medical University Joint Project), The scientific research project of the internal research institution in the medical and health unit of Yunnan Province, Funded by Bethune Langmu Young and Middle-aged Eye Research Fund.
Abstract (Originalsprache)
Background
Vascular endothelial growth factor (VEGF) signaling pathway plays an important role in the progression of diabetic retinopathy (DR). The glycosylation modification process of many key functional proteins in DR patients is abnormal. However, the potential involvement of abnormal N-glycoproteins in DR progression remains unclear.
Methods
Glycoproteomic profiling of the vitreous humor was performed. The level of protein and N-glycoprotein was confirmed by Western blot and Lectin blot, respectively. The cell viability and migration efficiency were detected by CCK-8 and Transwell assay. Flow cytometry was conducted to analyze the level of cell apoptosis and reactive oxygen specie. Malondialdehyde, superoxide dismutase activity and VEGF content were detected by Enzyme linked immunosorbent assays. The interaction of metalloproteinase 1 (TIMP-1) with N-acetylglucosamine transferase V (GnT-V) was detected by GST pull-down. Hematoxylin and eosin staining and choroidal and retinal flat mount stained with fluorescein isothiocyanate-Dextran assay were used for functional research in vivo.
Results
We found that N-glycosylation was up-regulated in DR rats and high glucose (HG)-induced human retinal pigment epithelium cell line ARPE-19. HG-induced inhibited the viability of ARPE-19 cells and promoted cell apoptosis and oxidative stress (OS), but these effects were reversed with kifunensine treatment, GnT-V knockdown and TIMP-1 mutation. Additionally, GnT-V binds to TIMP-1 to promote N-glycosylation of TIMP-1. Over-expression of GnT-V inhibited the viability of ARPE-19 cells and promoted cell apoptosis, OS and VEGF release, which these effects were reversed with TIMP-1 mutation. Interestingly, over-expression of GnT-V promoted retinal microvascular endothelial cells (RMECs) angiogenesis but was revered with TIMP-1 mutation, which was terminally boosted by VEGF-A treatment. Finally, knockdown of GnT-V relieved DR progression.
Conclusion
The findings indicate that GnT-V can promote RMECs angiogenesis and ARPE-19 cells injury through activation VEGF signaling pathway by increasing TIMP-1 N-glycosylation level, which provides a new theoretical basis for the prevention of DR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology Department, The First Affiliated Hospital of Kunming Medical University, No. 295, Xichang Road, Kunming, 650032, Yunnan, China.
- Ophthalmology Department, The Second Hospital of Ningbo, Ningbo, 315010, Zhejiang, China.
- Ophthalmology Department, The First Affiliated Hospital of Kunming Medical University, No. 295, Xichang Road, Kunming, 650032, Yunnan, China. li_yan_km@163.com.
Förderung
- Yunnan Province Applied Basic Research (Kunming Medical University Joint Project)
- The scientific research project of the internal research institution in the medical and health unit of Yunnan Province
- Funded by Bethune Langmu Young and Middle-aged Eye Research Fund
- Kunming Medical University Doctoral Innovation Fund Project
- National Natural Science Foundation of China Regional Project
- The Doctoral Research Fund Project of the First Affiliated Hospital of Kunming Medical University
Zitieren
APA
Xi, X., Yang, Y., Chen, Q., Ma, J., Wang, X., Deng, Y., Wang, X., & Li, Y. (2024). GnT-V-mediated aberrant N-glycosylation of TIMP-1 promotes diabetic retinopathy progression. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09388-7
Vancouver
Xi X, Yang Y, Chen Q, Ma J, Wang X, Deng Y, et al. GnT-V-mediated aberrant N-glycosylation of TIMP-1 promotes diabetic retinopathy progression. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09388-7
BibTeX
@article{Xi2024,
author = {Xi, Xiaoting and Yang, Yanni and Chen, Qianbo and Ma, Jia and Wang, Xuewei and Deng, Yachun and Wang, Xi and Li, Yan},
title = {GnT-V-mediated aberrant N-glycosylation of TIMP-1 promotes diabetic retinopathy progression},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09388-7}
}
EUVIMED